Presbyopia is, unfortunately, an inevitable condition associated with aging. Almost everyone over the age of 45 experiences this near-sight vision loss, which gradually gets worse and usually requires ...
On Thursday, the U.S. Food and Drug Administration approved LENZ Therapeutics, Inc.’s (NASDAQ:LENZ) VIZZ (aceclidine ophthalmic solution, previously known as LNZ100) 1.44%, the first and only ...
NEW YORK (Reuters) - Middle-aged Americans who have ditched their contact lenses because they can no longer read menus, or anything at close range, may now have a better alternative to grandfatherly ...
The Companies plan to file an application with the FDA in the second half of 2025. Topline data were announced from a phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for the ...
Credit: Lenz Therapeutics. Aceclidine is a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, thereby creating a pinhole effect that extends focus depth to improve ...
People with so-called "resting squint face" may seem like they are perpetually angry, but they may just be having trouble seeing. Focusing on close objects becomes increasingly difficult as people age ...
Each year, more than 30 million people globally receive surgery to correct cataracts. As many people age, the crystalline lenses in their eyes become cloudy and obstruct their vision, but a simple and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback